Overview


According to FutureWise analysis the market for cardiac pacemakers in 2023 is US$ 5 billion, and is expected to reach US$ 7.52 billion by 2031 at a CAGR of 5.2%.

A cardiac pacemaker is a medical device implanted under the chest area's skin to regulate the heartbeat in patients with irregular heart rhythms or arrhythmias. It is a small, battery-operated device that generates electrical impulses to stimulate the heart muscles to contract and pump blood. Cardiac pacemakers treat various conditions, such as bradycardia (slow heart rate), tachycardia (fast heart rate), heart failure, and cardiac arrest. These conditions can cause dizziness, fatigue, fainting, and shortness of breath and can be life-threatening if left untreated. The pacemaker is used to send electrical signals to the heart muscles, which regulate the heartbeat and ensure that the heart pumps blood effectively. The pacemaker is programmed to deliver electrical signals at a specific rate and rhythm, depending on the patient's needs. The device is connected to the heart via one or more leads, which are tiny wires that carry electrical signals to the heart.

Cardiac pacemakers are an essential treatment option for patients with heart rhythm disorders. They can help to improve symptoms, such as fatigue and dizziness, and reduce the risk of complications, such as fainting and sudden cardiac arrest. Pacemakers can also improve the quality of life for patients by allowing them to participate in daily activities, such as exercise, without experiencing symptoms. Several types of cardiac pacemakers are available, including single-chamber, dual-chamber, and biventricular pacemakers. The type of pacemaker used will depend on the patient's condition and individual needs. For example, single-chamber pacemakers are used for patients with a slow heartbeat, while dual-chamber pacemakers are used for patients with more complex heart rhythm disorders.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Cardiac Pacemakers Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Cardiac Pacemakers Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
  • Medtronic
  • Abbott., Inc.
  • Boston Scientific Corporation
  • Biotronik
  • Lepu Medical
  • Sorin Group
  • Medico S.P.A.
  • Oscor Inc.
  • LivaNova
  • Microport
  • St. Jude Medical Inc.
  • Osypka Medical GmbH
  • Pacetronix
  • Medicoweb

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Cardiac Pacemakers Market:

In June 2021, Micra AV, a miniature pacemaker that uses a minimally invasive method to provide patients with atrioventricular (AV) block with advanced pacing technology, was introduced by India Medtronic Private Limited. The apparatus is the first pacemaker to detect atrial activity without a lead or other device in the heart's upper chamber.

The worldwide cardiac pacemaker market has grown significantly in recent years, owing to rising cardiovascular disease incidence and an aging population. One of the key drivers of the cardiac pacemaker market is the rising incidence of cardiovascular diseases, such as atrial fibrillation, heart failure, and cardiac arrest, which has led to an increase in the number of cardiac pacemaker procedures. Additionally, the growing elderly population is at a higher risk of developing cardiovascular diseases and is driving demand for cardiac pacemakers. The market is also being influenced by technological advancements in cardiac pacemaker devices, such as smaller and more efficient devices, improved battery life, and wireless connectivity. These advancements have led to increased patient comfort, longer device lifespan, and better monitoring and management of cardiac rhythms. The growing need for minimally invasive treatments is another major factor driving the cardiac pacemaker market. The development of new technologies, such as leadless pacemakers, has made it possible to implant pacemakers without the need for a surgical incision, resulting in reduced recovery time, fewer complications, and increased patient comfort.

However, despite the positive growth trends, the cardiac pacemaker market also faces challenges. One of the major challenges is the high cost of pacemaker devices and procedures, which may limit their adoption, particularly in developing countries. In addition, the regulatory approval process for cardiac pacemakers can be time-consuming and expensive, which may limit the availability of new and innovative devices.

By Type

  • Implantable
  • External

By Technology

  • Biventricular
  • Single Chambered
  • Dual Chambered
  • Others

By Application

  • Arrhythmias
  • Atrial Fibrillation
  • Bradycardia
  • Tachycardia
  • Others

By End User

  • Hospitals
  • Cardiac Care Centers
  • Ambulatory
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. In terms of revenue, North America emerged as the largest regional market. The high prevalence of cardiovascular illness and excessive obesity all contribute to its large market size. The rise of cardiac disorders necessitates the use of cardiovascular devices, monitoring, and diagnostic tools. As a result, there is a rising requirement for improved treatment using innovative medical equipment, which may drive the market under consideration.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Cardiac Pacemakers Market By Type, By Technology, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Technologyology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Cardiac Pacemakers Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview

    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cardiac Pacemakers Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.   Global Cardiac Pacemakers Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Cardiac Pacemakers Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Implantable
        2. External

  • 8.   Global Cardiac Pacemakers Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Biventricular
        2. Single Chambered
        3. Dual Chambered
        4. Others

  • 9.   Global Cardiac Pacemakers Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Arrhythmias
        2. Atrial Fibrillation
        3. Bradycardia
        4. Tachycardia
        5. Others

  • 10.   Global Cardiac Pacemakers Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospitals
        2. Cardiac Care Centers
        3. Ambulatory
        4. Others

  • 11.   North America Cardiac Pacemakers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Cardiac Pacemakers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Cardiac Pacemakers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Cardiac Pacemakers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts)

    •   1. Medtronic
         1.1. Company Overview
         1.2. Type Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott., Inc.
         2.1. Company Overview
         2.2. Type Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boston Scientific Corporation
         3.1. Company Overview
         3.2. Type Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Biotronik
         4.1. Company Overview
         4.2. Type Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Lepu Medical
         5.1. Company Overview
         5.2. Type Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Sorin Group
         6.1. Company Overview
         6.2. Type Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Medico S.P.A.
         7.1. Company Overview
         7.2. Type Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Oscor Inc.
         8.1. Company Overview
         8.2. Type Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. LivaNova
         9.1. Company Overview
         9.2. Type Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Microport.
         10.1. Company Overview
         10.2. Type Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. St. Jude Medical Inc.
         11.1. Company Overview
         11.2. Technology Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Osypka Medical GmbH
         12.1. Company Overview
         12.2. Technology Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Pacetronix
         13.1. Company Overview
         13.2. Technology Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Medicoweb
         14.1. Company Overview
         14.2. Technology Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11